波音游戏-波音娱乐城赌球打不开

CityUHK’s IDM establishes partnership with Korea’s Samsung Advanced Institute for Health Sciences & Technology

 

M Yang
The MoU is signed by Professor Yang (left) and Professor Chang in Seoul, Korea.

The Institute of Digital Medicine (IDM) of City University of Hong Kong (CityUHK) and the Samsung Advanced Institute for Health Sciences & Technology (SAIHST) in Korea signed a Memorandum of Understanding (MoU) in Seoul on 18 March. It aims to establish collaboration on health-related research, particularly in cell and gene therapy, bioinformatics and biomedical engineering, as well as talent development and commercialising digital health solutions to benefit society.

The MoU was signed by Professor Michael Yang Mengsu, Senior Vice-President (Innovation and Enterprise) at CityUHK, and Professor Chang Yun Sil, Director of SAIHST.

SAIHST is a leading institute, jointly established by industry – Samsung Group, a hospital – Samsung Medical Center, and academia – Sungkyunkwan University (SKKU) – to advance research and nurture professional experts to lead the future of biomedical sciences. SAIHST is Korea’s first graduate school of interdisciplinary convergence medical science to conduct healthcare-focused research and education. The institute partnered with universities and research institutes in more than 10 countries, such as the United States, Canada, the United Kingdom, France, and partnership with domestic and global pharmaceutical companies, large corporations and biotech firms.

IDM was established in April 2024. In collaboration with renowned universities and medical schools around the world, as well as clinical and industry partners and health tech investors, IDM utilises CityUHK’s research strengths in engineering, data science and life science to develop innovative technologies to explore digital health solutions, for the long-term benefit of doctors and patients.

 “Global collaboration is crucial for the development of digital medicine,” said Professor Freddy Boey, President of CityUHK. “The partnership between IDM and SAIHST marks a significant milestone in advancing health technology innovation. With CityUHK’s dynamic innovation and entrepreneurial ecosystem, I am confident that our joint efforts will empower our future leaders on the global stage and create a positive impact on Hong Kong, Korea, and beyond.”

photo1
CityUHK's IDM and the SAIHST in Korea have established collaboration to advance health-related research, and promote talent development and commercialising digital health solutions, benefiting society in the long term.

IDM and SAIHST will establish talent-nurturing collaboration with an international perspective. SAIHST will support eligible top-tier researchers and scientists by facilitating their visits to Hong Kong, participating in programmes offered by the CityUHK Academy of Innovation, and providing internship opportunities for CityUHK students.

The two parties will strengthen their partnership in health-related innovations through CityUHK’s HK Tech 300 programme, jointly transforming innovative ideas into practical applications and promoting the development of deep-tech start-ups.

Following the signing ceremony, CityUHK's IDM delegation held discussions with professors from four SAIHST departments: Health Sciences and Technology, Digital Health, Medical Device Management and Research, and Clinical Research Design and Evaluation, and shared the development of CityUHK's IDM.

YOU MAY BE INTERESTED

Contact Information

Communications and Institutional Research Office

Back to top
真人888| 大发888官方下载| 百家乐官网六手变化混合赢家打法| 真钱百家乐官网五湖四海全讯网| 澳门百家乐官网赌客| 休闲百家乐官网的玩法技巧和规则 | 百家乐真人真钱| 玩百家乐免费| 六合彩彩图| 都昌县| 番禺百家乐官网电器店| 博彩百家乐龙虎| 宝马百家乐的玩法技巧和规则| 大发888注册送钱| 今晚六合彩开奖结果| 百家乐官网轮盘怎么玩| 米其林百家乐官网的玩法技巧和规则| 玩百家乐官网技巧巧| 百家乐桩闲落注点| 大发888客户端| 百家乐官网视频游戏视频| 百家乐网址多少| 大发888官方下载网站| 时时博在线娱乐城| 东莞百家乐官网的玩法技巧和规则 | 百家乐是不是有假| 大发888怎么赢钱| 瑞丰国际娱乐城| 荷规则百家乐官网的玩法技巧和规则 | 真人百家乐娱乐好玩| 大发888娱乐城34| 澳门赌百家乐官网心法| 百家乐赌场优势| 丹东亿酷棋牌世界官方下载| 百家乐官网庄9点| 百家乐智能系统| 金都百家乐官网现金网| 大发百家乐现金网| 大发888怎么玩能赢| 夜总会百家乐官网的玩法技巧和规则| 大发888娱乐场下载客户端|